Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 2000

View Archived Issues

Study shows xylitol chewing gum is effective against oral bacteria

Vitamin E therapy lowers inflammation and vascular disease risk in diabetic patients

Researchers determine the structure of antibody-receptor complex key to allergies and asthma

Genzyme Molecular Oncology makes progress in cancer vaccine, antiangiogenic research

Olprinone demonstrates efficacy in dog model of pulmonary hypertension

Nesiritide shows promise as short-term treatment of decompensated CHF

Clinical safety results reported for Isis c-Raf kinase antisense oligonucleotide

Licensing opportunity from NIH: TNF receptor domain

Early aspirin of benefit for wide range of ischemic stroke patients

Vaniqa approved by FDA for women with unwanted facial hair

Licensing opportunity from NIH: multiple peptide conjugate system for HIV

Millennium completes acquisition of Cambridge Discovery Chemistry

Blockade of growth factor inhibits diabetic nephropathy

Additional pivotal trial data reported for IntraDose

Pharmacia introduces first vaginal estrogen tablet in U.S.

New patent covering nonsedating barbiturates granted to Taro

Transgene advances gene therapy products

GPC Biotech initiates strategic alliance with Cytovia for oncology compound

Clinical trial results disappointing for Provigil as treatment for adult ADHD

Antisense modulators of human sentrin useful for cancer and primary biliary cirrhosis

5-HT1A receptor ligands and their use in CNS disorders

Apoptosis-inducing retinamides described by Roche

Novel tubulin-binding compounds designed at Tularik

Akzo Nobel presents new agents for controlling fertility

Improved recombinant HBsAg for use in vaccines under study at Merck

CuraGen researchers identify SECX polypeptides useful for diagnosis, treatment of cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...